HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

seryl- leucyl- isoleucyl- - glycyl- lysyl- valine

derived from amino-terminus of proteinase-activated receptor 2 (PAR-2)
Also Known As:
SLIGKV; Ser-Leu-Ile-Gly-Lys-Val
Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Bataille, A: 1 article (12/2021)
2. Brun, C: 1 article (12/2021)
3. Carré, J-L: 1 article (12/2021)
4. Fluhr, J W: 1 article (12/2021)
5. Le Gall-Ianotto, C: 1 article (12/2021)
6. Lebonvallet, N: 1 article (12/2021)
7. Leschiera, R: 1 article (12/2021)
8. Misery, L: 1 article (12/2021)
9. Oddos, T: 1 article (12/2021)
10. Pennec, J-P: 1 article (12/2021)

Related Diseases

1. Neoplasms (Cancer)
2. Pancreatic Neoplasms (Pancreatic Cancer)
3. Necrosis
4. Inflammation (Inflammations)
5. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. Trypsin
2. Peptides (Polypeptides)
3. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
4. Nerve Growth Factor (NGF)
5. E-Selectin
6. Interleukin-8 (Interleukin 8)
7. Phosphotransferases (Kinase)
8. Peptide Hydrolases (Proteases)
9. Capsaicin (Zostrix)
10. 2-furoyl-LIGRLO-amide

Related Therapies and Procedures

1. Aftercare (After-Treatment)